Gw&K Investment Management, LLC Ligand Pharmaceuticals Inc Transaction History

Gw&K Investment Management, LLC

$11.7 Billion
Q3 2024

A detailed history of Gw&K Investment Management, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 37,761 shares of LGND stock, worth $4.33 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

37,761

Previous 39,018 3.22%

Holding current value

$4.33 Million

Previous $3.29 Million 14.93%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$82.7 - $110.11 $103,953 - $138,408	-1,257 Reduced 3.22%	37,761 $3.78 Million
Q2 2024 Aug 12, 2024	SELL	$68.53 - $87.91 $51,191 - $65,668	-747 Reduced 1.88%	39,018 $3.29 Million
Q1 2024 May 08, 2024	SELL	$68.64 - $89.2 $1.07 Million - $1.39 Million	-15,570 Reduced 28.14%	39,765 $2.91 Million
Q4 2023 Feb 09, 2024	BUY	$49.57 - $72.63 $887,550 - $1.3 Million	17,905 Added 47.84%	55,335 $3.95 Million
Q3 2023 Nov 09, 2023	SELL	$58.86 - $72.67 $39,907 - $49,270	-678 Reduced 1.78%	37,430 $2.24 Million
Q2 2023 Aug 09, 2023	SELL	$69.53 - $79.33 $52,147 - $59,497	-750 Reduced 1.93%	38,108 $2.75 Million
Q1 2023 May 09, 2023	BUY	$65.67 - $77.08 $575,531 - $675,529	8,764 Added 29.12%	38,858 $2.86 Million
Q4 2022 Feb 10, 2023	SELL	$61.72 - $96.74 $19,133 - $29,989	-310 Reduced 1.02%	30,094 $2.01 Million
Q3 2022 Nov 09, 2022	SELL	$0.01 - $107.56 $32 - $350,215	-3,256 Reduced 9.67%	30,404 $2.62 Million
Q2 2022 Aug 09, 2022	SELL	$74.52 - $117.06 $90,392 - $141,993	-1,213 Reduced 3.48%	33,660 $3 Million
Q1 2022 May 09, 2022	BUY	$94.99 - $151.56 $889,391 - $1.42 Million	9,363 Added 36.7%	34,873 $3.92 Million
Q4 2021 Feb 11, 2022	BUY	$127.69 - $165.85 $3.26 Million - $4.23 Million	25,510 New	25,510 $3.94 Million

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Account

Gw&K Investment Management, LLC Ligand Pharmaceuticals Inc Transaction History